Gilead Sciences
GILD
#92
Rank
NZ$311.31 B
Marketcap
NZ$250.77
Share price
1.32%
Change (1 day)
23.57%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.23

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$11.01. In 2024 the company made an earnings per share (EPS) of NZ$0.64 a decrease over its 2023 EPS that were of NZ$7.68.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.231650.16%
2024NZ$0.64-91.65%
2023NZ$7.6823.98%
2022NZ$6.19-25.86%
2021NZ$8.364850%
2020NZ$0.17-97.64%
2019NZ$7.160.9%
2018NZ$7.0918.71%
2017NZ$5.98-64.88%
2016NZ$17.02-18.45%
2015NZ$20.8655.28%
2014NZ$13.44296.02%
2013NZ$3.3917.89%
2012NZ$2.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.80 70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.30-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.04-63.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.86 253.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.19 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.55 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.55-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$24.19 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.33 12.07%๐Ÿ‡บ๐Ÿ‡ธ USA